Wall Street Journal - Sept 21
Sept 21 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
- Coinbase Global Inc COIN.O won't offer a lending program that drew the threat of enforcement action from U.S. regulators. Link
- Pfizer Inc PFE.N and partner BioNTech SE 22UAy.DE said their COVID-19 vaccine was found to be safe in children ages five to 11 years in a late-stage study and generated a strong immune response in them, bringing the prospect of broader vaccination coverage closer. Link
- Royal Dutch Shell PLC RDSa.AS has agreed to sell all of its assets in the Permian basin, the most active U.S. oil field, to ConocoPhillips COP.N for around $9.5 billion in cash. Link
- General Motors Co GM.N said it would start next month to fix Chevrolet Bolt electric cars that were recalled for fire risk, although many owners likely will have to wait months to receive the remedy. Link (Compiled by Bengaluru newsroom)
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.